mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family

Growth Factors

Volumn 17, Issue 2, 1999, Pages 125-137

  Fu, Xinyu ^a   Roberts, W Gregory ^c   Nobile, Valentina ^b   Shapiro, Robert ^b   Kamps, Mark P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; E2a Pbx1; Growth factor; Oncogene; Ribonuclease

Indexed keywords

ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; DINUCLEOTIDE; ONCOPROTEIN; PANCREATIC RIBONUCLEASE; TRANSFER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; CREMASTER MUSCLE; ELECTRON MICROSCOPY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; ESCHERICHIA COLI; FIBROBLAST; GENETIC TRANSFORMATION; MITOCHONDRION; MOUSE; MULTIGENE FAMILY; NONHUMAN; ONCOGENE; POLYSOME; PRIORITY JOURNAL; PROTEIN FAMILY; ROUGH ENDOPLASMIC RETICULUM; TRANSCRIPTION INITIATION;

ESCHERICHIA COLI;

EID: 0033458028     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977199909103521     Document Type: Article

References (56)

1. Acharya, K.R., Shapiro, R., Allen, S.C., Riordan, J.F. and Vallee, B.L. (1994) Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc. Natl. Acad. Sci. USA 91, 2915-2919.
2. Acharya, K.R., Shapiro, R., Riordan, J.F. and Vallee, B.L. (1995) Crystal structure of bovine angiogenin at 1.5-A resolution. Proc. Natl. Acad. Sci. USA 92, 2949-2953.
3. Bicknell, R. and Vallee, B.L. (1988) Angiogenin activates endothelial cell phospholipase C. Proc. Natl. Acad. Sci. USA 85, 5961-5965.
4. Bond, M.D. and Vallee, B.L. (1990) Isolation and sequencing of mouse angiogenin DNA. Biochem. Biophys. Res. Commun. 171, 988-995.
5. Bond, M.D., Strydom, D.J. and Vallee, B.L. (1993) Characterization and sequencing of rabbit, pig and mouse angiogenins: discernment of functionally important residues and regions. Biochim. Biophys. Acta 1162, 177-186.
6. Brown, W.E., Nobile, V., Subramanian, V. and Shapiro, R. (1995) The mouse angiogenin gene family: structures of an angiogenin-related protein gene and two pseudogenes. Genomics 29, 200-206.
7. Curran, T.P., Shapiro, R. and Riordan, J.F. (1993) Alteration of the enzymatic specificity of human angiogenin by site-directed mutagenesis. Biochemistry 32, 2307-2313.
8. Dedera, D.A., Waller, E.K., Lebrun, D.P., Sen-Majumdar, A., Stevens, M.E., Barsh, G.S. and Cleary, M.L. (1993) Chimeric homeobox gene E2a-Pbx1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 74, 833-843.
9. Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. and Jain, R.K. (1996) Quantitation and physiological characterization of angiogenic vessels in mice. Am. J. Path. 149, 59-71.
10. Fett, J.W., Strydom, D.J., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F. and Vallee, B.L. (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480-5486.
11. Fu, X. and Kamps, M.P. (1997) E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH3T3 fibroblasts. Mol. Cell. Biol. 17, 1503-1512.
12. Godspodarowicz, D., Bialecki, H. and Thakral, T.K. (1979) The angiogenic activity of the fibroblast and epidermal growth factor. Exp. Eye Res. 28, 501-514.
13. Hallahan, T.W., Shapiro, R. and Vallee, B.L. (1991) Dual site model for the organogenic activity of angiogenin. Proc. Natl. Acad. Sci. USA 188, 2222-2226.
14. Hallahan, T.W., Shapiro, R., Strydom, D.J. and Vallee, B.L. (1992) Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin. Biochemistry 31, 8022-8029.
15. Harper, J.W. and Vallee, B.L. (1988) Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin. Proc. Natl. Acad. Sci. USA 85, 7139-7143.
16. Harper, J.W. and Vallee, B.L. (1989) A covalent angiogenin/ ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry 28, 1875-1884.
17. Harper, J.W., Fox, E.A., Shapiro, R. and Vallee, B.L. (1990) Mutagenesis of residues flanking Lys-40 enhances the enzymatic activity and reduces the angiogenic potency of angiogenin. Biochemistry 29, 7297-7302.
18. Hu, G.-F. and Riordan, J.F. (1993) Angiogenin enhances actin acceleration of plasminogen activation. Biochem. Biophys. Res. Commun. 197, 682-687.
19. Hu, G.-F., Riordan, J.F. and Vallee, B.L. (1994) Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc. Natl. Acad. Sci. USA 91, 12096-12100.
20. Hu, G.-F., Strydom, D.J., Fett, J.W., Riordan, J.F. and Vallee, B.L. (1993) Actin is a binding protein for angiogenin. Proc. Natl. Acad. Sci. USA 90, 1217-1221.
21. Hu, G.-F., Riordan, J.F. and Vallee, B.L. (1997) A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc. Natl. Acad. Sci. USA 94, 2204-2209.
22. Jimi, S., Ito, K., Kohno, K., Ono, M., Kuwano, M., Itagaki, Y. and Ishikawa, H. (1995) Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem. Biophys. Res. Commun. 211, 476-483.
23. Kamps, M.P., Murre, C., Sun, X. and Baltimore, D. (1990) A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60, 547-555.
24. Kamps, M.P., Look, T. and Baltimore, D. (1991) The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2a-Pbx1 fusion proteins with differing transforming potentials. Genes Dev. 5, 358-368.
25. Kamps, M.P. and Baltimore, D. (1993) E2a-Pbx1, the t(1;19) translocation protein of human pre-B cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol. Cell. Biol. 13, 351-357.
26. Kamps, M.P. and Wright, D. (1994) Oncoprotein E2a-Pbx1 immortalizes a primary myeloid progenitor without abrogating its factor-dependence. Oncogene 9, 3159-3166.
27. Knighton, D., Ausprunk, D., Tapper, D. and Folkman, J. (1977) Avascular and vascular phases of tumor growth in the chick embryo. Br. J. Cancer 35, 347-356.
28. Knoepfler, P.S., Calvo, K.R., Chen, H., Antonarakis, S.E. and Kamps, M.P. (1997) Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc. Natl. Acad. Sci. USA 94, 14553-14558.
29. Lu, Q., Wright, D.D. and Kamps, M.P. (1994) Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol. Cell. Biol. 14, 3938-3948.
30. Lu, Q. and Kamps, M.P. (1997) Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specificities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain -demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene 14, 75-83.
31. Maes, P., Damart, D., Rommens, C., Montreuil, J., Spik, G. and Tartar, A. (1988) The complete amino acid sequence of bovine milk angiogenin. Febs Letters 241, 41-45.
32. McKinney, R.V., Singh, B.B. and Brewer, P.D. (1977) Fenestrations in regenerating skeletal muscle capillaries. Am. J. Anat. 150, 213-218.
33. Moenner, M., Gusse, M., Hatzi, E. and Badet, J. (1994) The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur. J. Biochem. 226, 483-490.
34. Monica, K., Galili, N., Nourse, J., Saltman, D. and Cleary, M.L. (1991) PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol. Cell. Biol. 11, 6149-6157.
35. Moroianu, J., Fett, J.W., Riordan, J.F. and Vallee, B.L. (1993) Actin is a surface component of calf pulmonary artery endothelial cells in culture. Proc. Natl. Acad. Sci. USA 90, 3815-3819.
36. Moroianu, J. and Riordan, J.F. (1994) Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenicactivity. Proc. Natl. Acad. Sci. USA 91, 1677-1681.
37. Nobile, V., Vallee, B.L. and Shapiro, R. (1996) Characterization of mouse angiogenin-related protein: implications for functional studies on angiogenin. Proc. Natl. Acad. Sci. USA 93, 4331-4335.
38. Nourse, J., Mellentin, J.D., Galili, N., Wilkinson, J., Stanbridge, E., Smith, S.D. and Cleary, M.L. (1990) Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60, 535-545.
39. Olson, K.A., French, T.C., Vallee, B.L. and Fett, J.W. (1994) A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res. 54, 4576-4579.
40. Olson, K.A., Fett, J.W., French, T.C., Key, M.E. and Vallee, B.L. (1995) Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. USA 92, 442-446.
41. Roberts, W.G. and Palade, G.E. (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108, 2369-2379.
42. Roberts, W.G. and Palade, G.E. (1997) Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57, 765-772.
43. Russo, N., Shapiro, R., Acharya, K.R., Riordan, J.F. and Vallee, B.L. (1994) Role of glutamine-117 in the ribonucleolytic activity of human angiogenin. Proc. Natl. Acad. Sci. USA 91, 2920-2924.
44. Rybak, S.M., Fett, J.W., Yao, Q.Z. and Vallee, B.L. (1987) Angiogenin mRNA in human tumor and normal cells. Biochem. Biophys. Res. Commun. 146, 1240-1248.
45. Schoefl, G.I. (1963) Studies on inflammation III. Growing capillaries: their structure and permeability. Virchows Arch. Path. Anat. 33, 97-141.
46. Shapiro, R., Riordan, J.F. and Vallee, B.L. (1986) Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 25, 3527-3532.
47. Shapiro, R., Strydom, D.J., Olson, K.A. and Vallee, B.L. (1987) Isolation of angiogenin from normal human plasma. Biochemistry 26, 5141-5146.
48. Shapiro, R., Harper, J.W., Fox, E.A., Jansen, H.W., Hein, F. and Uhlmann, E. (1988) Expression of Mct-(-1) angiogenin in Escherichia coli: conversion to the authentic < Glu-1 protein. Anal. Biochem. 175, 450-461.
49. Shapiro, R., Fox, E.A. and Riordan, J.F. (1989) Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. Biochemistry 28, 1726-1732.
50. Shapiro, R. and Vallee, B.L. (1989) Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry 28, 7401-7408.
51. Shapiro, R. and Vallee, B.L. (1992) Identification of functional arginines in human angiogenin by site-directed mutagenesis. Biochemistry 31, 12477-12485.
52. Shapiro, R. (1998) Structural features that determine the enzymatic potency and specificity of human angiogenin: Threonine-80 and residues 58-70 and 116-123. Biochemistry (in Press).
53. Strydom, D.J., Fett, J.W., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F. and Vallee, B.L. (1985) Amino acid sequence of human tumor derived angiogenin. Biochemistry 24, 5486-5494.
54. Strydom, D.J., Bond, M.D. and Vallee, B.L. (1997) An angiogenic protein from bovine serum and milk - purification and primary structure of angiogenin-2. Eur. J. Biochem. 247, 535-544.
55. van Dijk, M.A., Voorhoeve, P. and Murre, C. (1993) Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B cell acute lymphoblastoid leukemia. Proc. Natl. Acad. Sci. USA 90, 6061-6065.
56. van Dijk, M.A., Peltenburg, L.T. and Murre, C. (1995) Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech. Dev. 52, 99-108.